| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:725.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology, The University of Texas Health Science Center at San Antonio (Q.H.C., G.M.T.), San Antonio, Tex; and the Department of Pharmacology and Toxicology, Michigan State University (J.R.H.), East Lansing, Mich.
Correspondence to Glenn M. Toney, PhD, Department of Physiology-7756, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 782293900. E-mail toney{at}uthscsa.edu
Acute blockade of
-aminobutyric acid (GABA)-A receptors in the hypothalamic paraventricular nucleus (PVN) increases mean arterial pressure (MAP), heart rate (HR), and sympathetic nerve activity (SNA). However, the underlying neural mechanisms have not been fully determined. We tested the hypothesis that responses to GABA-A receptor blockade in the PVN require activation of local ionotropic excitatory amino acid (EAA) receptors. MAP, HR, and renal SNA responses to unilateral PVN microinjection of bicuculline methobromide (BIC, 0.1 nmol) were recorded before and after ipsilateral PVN injection of either vehicle (saline), the nonselective ionotropic EAA receptor antagonist kynurenate (KYN), the NMDA receptor antagonist D(-)-2-amino-5-phosphonopentanoic acid (AP5), or the non-NMDA receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium (NBQX). Responses to PVN-injected BIC were unaltered by vehicle injection. In contrast, injection of KYN (7.2 nmol; n=4) nearly abolished ABP and renal SNA responses to BIC (P<0.01) and significantly attenuated (P<0.05) HR responses as well. Similarly, graded doses of AP5 (0.6, 3, and 6 nmol) and NBQX (0.26, 1.3, and 2.6 nmol) reduced responses to PVN-injected BIC in a dose-related manner, with the 3 nmol (n=7) and 1.3 nmol (n=6) doses producing maximal effects (P<0.05). KYN, AP5, and NBQX did not affect baseline parameters. Effects of a cocktail containing AP5 (3 nmol) and NBQX (1.3 nmol) were greater (P<0.01) than either antagonist alone and were not statistically different from KYN. These data indicate that cardiovascular and renal sympathetic responses to acute GABA-A receptor blockade in the PVN require local actions of EAAs at both NMDA and non-NMDA receptors.
Key Words: heart failure hypertension, arterial sympathetic nervous system arterial pressure
This article has been cited by other articles:
![]() |
D.-P. Li, Q. Yang, H.-M. Pan, and H.-L. Pan Pre- and postsynaptic plasticity underlying augmented glutamatergic inputs to hypothalamic presympathetic neurons in spontaneously hypertensive rats J. Physiol., March 15, 2008; 586(6): 1637 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shi, S. D. Stocker, and G. M. Toney Organum vasculosum laminae terminalis contributes to increased sympathetic nerve activity induced by central hyperosmolality Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2279 - R2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Park, S. Skalska, S. Son, and J. E. Stern Dual GABAA receptor-mediated inhibition in rat presympathetic paraventricular nucleus neurons J. Physiol., July 15, 2007; 582(2): 539 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Freeman and V. L. Brooks AT1 and glutamatergic receptors in paraventricular nucleus support blood pressure during water deprivation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1675 - R1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-P. Li and H.-L. Pan Glutamatergic Inputs in the Hypothalamic Paraventricular Nucleus Maintain Sympathetic Vasomotor Tone in Hypertension Hypertension, April 1, 2007; 49(4): 916 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni and D. A. Morgan Hypothalamic Arcuate Nucleus Mediates the Sympathetic and Arterial Pressure Responses to Leptin Hypertension, March 1, 2007; 49(3): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsbeek, I. F. Palm, S. E. La Fleur, F. A. J. L. Scheer, S. Perreau-Lenz, M. Ruiter, F. Kreier, C. Cailotto, and R. M. Buijs SCN Outputs and the Hypothalamic Balance of Life. J Biol Rhythms, December 1, 2006; 21(6): 458 - 469. [Abstract] [PDF] |
||||
![]() |
Y.-F. Li, K. L. Jackson, J. E. Stern, B. Rabeler, and K. P. Patel Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2847 - H2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-P. Li and H.-L. Pan Plasticity of GABAergic control of hypothalamic presympathetic neurons in hypertension Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1110 - H1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, D.-P. Li, and H.-L. Pan Presynaptic {alpha}1 Adrenergic Receptors Differentially Regulate Synaptic Glutamate and GABA Release to Hypothalamic Presympathetic Neurons J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 733 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Schlenker Integration in the PVN: another piece of the puzzle Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R653 - R655. [Full Text] [PDF] |
||||
![]() |
M. R. Zahner and H.-L. Pan Role of paraventricular nucleus in the cardiogenic sympathetic reflex in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R420 - R426. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kalsbeek, S. La Fleur, C. Van Heijningen, and R. M. Buijs Suprachiasmatic GABAergic Inputs to the Paraventricular Nucleus Control Plasma Glucose Concentrations in the Rat via Sympathetic Innervation of the Liver J. Neurosci., September 1, 2004; 24(35): 7604 - 7613. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Stocker, K. J. Keith, and G. M. Toney Acute inhibition of the hypothalamic paraventricular nucleus decreases renal sympathetic nerve activity and arterial blood pressure in water-deprived rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R719 - R725. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |